Method development for simultaneous analysis of Amyloid β (Aβ) proteins

Bioanalytical

Method development for simultaneous analysis of Amyloid β (Aβ) proteins

27 Aug, 2019

Published over 7 years ago. See the latest and most current information on Bioanalytical.

Amyloid β (Aβ) are peptides of 36–43 amino acids that are the main components of amyloid plaques. The analysis of Aβ is not trivial as the Aβ peptides such as Aβ (1–42) are highly hydrophobic which leads to the formation of aggregates.

YMC has developed a method for the simultaneous determination of four Aβ using YMC-Triart Bio C4. As the hydrophobic Aβ have a tendency to form aggregates a stationary phase with lower hydrophobicity and a larger pore is needed. Therefore, YMC-Triart Bio C4 is the optimum column for this demanding separation. Due to the high chemical stability of YMC-Triart Bio C4 it is possible to do rapid method optimisation for complex mixtures of peptides and proteins utilising the wide pH and temperature range available. YMC-Triart Bio C4 is available with 3 and 5 μm for HPLC, as well as with fully scalable 1.9 μm for UHPLC.

Latest News

Explore Our Other Sites

Labmate Online
Recognition has not kept pace with influence, say laboratory professionals
Explore more Arrow
Envirotech Online
AI-linked digital twins could move environmental science from monitoring to prediction, researchers argue
Explore more Arrow
Pollution Solutions Online
Vacuum technology enables efficient lithium-ion battery recycling with recovery rates of up to 95%
Explore more Arrow
Petro Online
Fine-tuned language models outperform larger general-purpose AI on fuel property prediction
Explore more Arrow